Skip to main content
Molecular & Cellular Proteomics

Main menu

  • Home
  • Articles
    • Current Issue
    • Papers in Press
    • Reviews and Minireviews
    • Special Issues
    • Editorials
    • Archive
    • Letters to the Editor (eLetters)
  • Info for
    • Authors
      • Editorial Policies
      • How to Submit
      • Manuscript Contents & Organization
      • Data Reporting Requirements
      • Publication Charges
    • Reviewers
    • Librarians
    • Advertisers
    • Subscribers
  • Guidelines
    • Proteomic Identification
      • Checklist (PDF)
      • Instructions for Annotated Spectra
      • Tutorial (PDF)
    • Clinical Proteomics
      • Checklist (PDF)
    • Glycomic Identification
      • Checklist (PDF)
    • Targeted Proteomics
      • Checklist (PDF)
    • Data-Independent Acquisition
      • Checklist (PDF)
    • Frequently Asked Questions
  • About
    • Mission Statement and Scope
    • Editorial Policies
    • Editorial Board
    • MCP Lectureships
    • Permissions and Licensing
    • Partners
    • Alerts
    • Contact Us

Submit

  • Submit
  • Publications
    • ASBMB
    • Molecular & Cellular Proteomics
    • Journal of Biological Chemistry
    • Journal of Lipid Research

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
  • Publications
    • ASBMB
    • Molecular & Cellular Proteomics
    • Journal of Biological Chemistry
    • Journal of Lipid Research
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Molecular & Cellular Proteomics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Papers in Press
    • Reviews and Minireviews
    • Special Issues
    • Editorials
    • Archive
    • Letters to the Editor (eLetters)
  • Info for
    • Authors
      • Editorial Policies
      • How to Submit
      • Manuscript Contents & Organization
      • Data Reporting Requirements
      • Publication Charges
    • Reviewers
    • Librarians
    • Advertisers
    • Subscribers
  • Guidelines
    • Proteomic Identification
      • Checklist (PDF)
      • Instructions for Annotated Spectra
      • Tutorial (PDF)
    • Clinical Proteomics
      • Checklist (PDF)
    • Glycomic Identification
      • Checklist (PDF)
    • Targeted Proteomics
      • Checklist (PDF)
    • Data-Independent Acquisition
      • Checklist (PDF)
    • Frequently Asked Questions
  • About
    • Mission Statement and Scope
    • Editorial Policies
    • Editorial Board
    • MCP Lectureships
    • Permissions and Licensing
    • Partners
    • Alerts
    • Contact Us
  • Submit
Research

Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer

Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Raja Sekhar Nirujogi, Min-Sik Kim, Srikanth S. Manda, Vered Stearns, Edward Gabrielson, Saraswati Sukumar and Akhilesh Pandey
Molecular & Cellular Proteomics November 1, 2015, First published on September 1, 2015, 14 (11) 2887-2900; https://doi.org/10.1074/mcp.M115.050484
Xinyan Wu
From the ‡McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhammad Saddiq Zahari
From the ‡McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santosh Renuse
§Institute of Bioinformatics, International Technology Park, Bangalore, 560066 India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raja Sekhar Nirujogi
§Institute of Bioinformatics, International Technology Park, Bangalore, 560066 India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min-Sik Kim
From the ‡McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Srikanth S. Manda
§Institute of Bioinformatics, International Technology Park, Bangalore, 560066 India;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vered Stearns
¶Department of Oncology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Edward Gabrielson
‖Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saraswati Sukumar
¶Department of Oncology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akhilesh Pandey
From the ‡McKusick-Nathans Institute of Genetic Medicine and Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205; ¶Department of Oncology; ‖Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: pandey@jhmi.edu
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Tamoxifen-resistant MCF7 cell line exhibits resistance to tamoxifen and increase in global phosphotyrosine levels. A, Inhibitory effect of different concentrations of tamoxifen on the proliferation of MCF7 tamoxifen-resistant (MCF7-TamR) cell line and MCF7 sensitive control (MCF7-CTRL) cell line. Cell proliferation was assessed using MTT assay after 7 days of treatment. Quantification was done relative to vehicle-treated MCF7-CTRL. Student's t test was performed for statistical analysis. B, Tumor size of xenograft on mice grown with either MCF7-TamR or MCF7-CTRL cell lines with estrogen (E2) supplementation and treated with or without tamoxifen (TAM). Two-way Anova test was performed for statistical analysis. C, Immunoblot of tyrosine phosphorylated proteins using the anti-phosphotyrosine antibody (pTyr) on the cell lysates or after immunoprecipitation (IP) with pTyr antibody. β-actin, heavy (H) chain and light (L) chain serve as loading control.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    Workflow of phosphoproteomic profiling of tamoxifen-resistant and sensitive cell line. MCF7 tamoxifen-resistant (MCF7-TamR) cell line was labeled with light amino acids and MCF7 tamoxifen-sensitive control (MCF7-CTRL) cell line was labeled with heavy amino acids, mixed in equal amounts, digested with trypsin and subjected to either anti-phosphotyrosine antibody enrichment or strong cation exchange (SCX) fractionation prior to TiO2-based phosphopeptide enrichment. The enriched phosphopeptides were then subjected to LC-MS/MS analysis.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    Phosphoproteomic profiling data analysis reveals global elevation of protein phosphorylation. A, Distribution of identified phosphorylated serine, threonine, and tyrosine residues in the combined data sets of anti-phosphotyrosine antibody- and TiO2- based phosphopeptide enrichments from all biological replicate samples. B, Density scatter plot of log2-transformed phosphopeptide ratios (MCF7-TamR versus MCF7-CTRL) from two biological replicates. Pearson coefficient correlation (R) is indicated. C, Distribution of phosphopeptides comparing the fold changes of phosphorylation levels of MCF7-TamR over MCF7-CTRL cells. Red dots: hyperphosphorylated peptides (>twofold), green dots: hypophosphorylated peptides (<0.5-fold). D, Top signaling pathways identified from pathway enrichment analysis of the hyperphosphorylated proteins (>twofold) in the MCF7-TamR cells. E, Cell morphology of MCF7-CTRL and MCF7-TamR viewed under phase contrast microscopy. F, Matrigel invasion assay of MCF7-CTRL and MCF7-TamR. Student's t test was performed for statistical analysis.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    Activation of focal adhesion pathways in tamoxifen resistance. A, Hyperphosphorylated and hypophosphorylated (MCF7-TamR versus MCF7-CTRL) proteins identified in the MCF7-TamR cells that are involved in the focal adhesion pathways. Protein phosphorylation sites and phospho-regulation patterns were specified with color-coded circles. Diagram adapted from Pathvisio, a pathway analysis tool. B-E, Representative MS spectra of hyperphosphorylated peptides of FAK2, FAK1, PXN and BCAR1.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    FAK2 is overexpressed and hyperphosphorylated in tamoxifen resistant cells. A, Western blot validation of phosphorylation sites of proteins involved in the focal adhesion pathway identified in phosphoproteomic profiling. β-actin serves as loading control. B, Increase in expression of FAK2 in MCF7 cells treated with tamoxifen short term or long term. C, Real-time RT-PCR analysis of FAK2 mRNA expression in MCF7-TamR and MCF7-CTRL cells. Student's t test was used for statistical analysis. D, Immunofluorescence staining of pY402 FAK2 in MCF7-CTRL and MCF7-TamR cells. Green: FAK2 pY402; Blue: DAPI staining of nuclei. E, Focal adhesions of each cell were counted and Student's t test was used for statistical analysis.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    FAK2 is a novel therapeutic target in tamoxifen-resistant breast cancer. A, Western blot analysis of siRNA knockdown of FAK2 (siFAK2) or control (siCTRL). β-actin serves as a loading control. B, Proliferation assay following siRNA knockdown of FAK2 (siFAK2) or control siRNA (siCTRL) with tamoxifen or vehicle. Student's t test was performed for statistical analysis. C, Western blot analysis of MCF7-CTRL and MCF7-TamR cells treated with two different siRNA against FAK2. Protein expression and phosphorylation levels of the proteins involved in the focal adhesion pathway were examined. D, The inhibitory effect of PF562271 on cell growth of MCF7-CTRL and MCF7-TamR cell. The IC50 curve was plotted using a nonlinear regression dose-response (variable slope) curve fit. E, Tumor volumes of mice xenograft grown with either MCF7-TamR or MCF7-CTRL cells with the treatment of PF562271 or DMSO control. Two-way Anova was performed for statistical analysis. F, Kaplan-Meier curve of metastasis-free survival of ER+ patients treated with tamoxifen. The patients were stratified based on expression of FAK2.

Tables

  • Figures
  • Additional Files
    • View popup
    Table I A list of representative regulated proteins involved in focal adhesion pathway
    Gene symbolPhosphopeptide sequenceProtein nameSiteTamR/CTRL
    PTK2BYIEDEDYyKASVTRLPIKfocal adhesion kinase 2 (FAK2)Y58025.74
    RHsMREEDFIQPSSRS7788.91
    PTK2YMEDSTYyKASKfocal adhesion kinase 1 (FAK1)Y6622.20
    GSIDREDGSLQGPIGNQHIyQPVGKPDPAAPPKY9462.74
    SRCY439
    FYNWTAPEAALyGRv-src viral oncogeneY4404.21
    YESY446
    BRAFsPQKPIVRv-raf oncogene homolog BS1510.45
    BCAR1RPGPGTLyDVPRbreast cancer anti-estrogen resistance 1Y4337.41
    AQQGLyQVPGPSPQFQSPPAKY1748.35
    PXNVGEEEHVySFPNKpaxillinY1243.42
    FIHQQPQSSsPVyGSSAKY94, S913.64
    TLN1STVLQQQyNRtalin 1Y4364.61
    TMQFEPSTMVyDACRY265.94
    FYNKLDNGGyYITTRFYN oncogeneY2132.80
    GAySLSIRY1854.14
    CRKYRPAsASVSALIGGRv-crk avian sarcoma virus CT10 oncogeneS1945.89
    JUNLAsPELERjun proto-oncogeneS733.68
    MAPK8 MAPK10TAGTSFMMTPyVVTRmitogen-activated protein kinase 8, 10Y1850.37
    Y226
    ACTG1EITALAPsTMKactin, gamma 1S3233.18
    ACTBactin, beta
    ACTN1HRPELIDyGKactinin, alpha 1Y1934.81
    ARHGAP5GGIDNPAITsDQELDDKKRho GTPase activating protein 5S12184.41
    RTHsDAsDDEAFTTSKS1173, S11763.91
    BADRMsDEFVDSFKKBCL2-associated agonist of cell deathS1184.99
    FLNACSGPGLsPGMVRfilamin A, alphaS14595.06
    APsVANVGSHCDLSLKS21524.92
    ILKNGtLNKHSGIDFKintegrin-linked kinaseT1812.25
    PAK2FYDsNTVKp21 protein (Cdc42/Rac)-activated kinase 2S1322.79
    DGFPsGTPALNAKS1522.04
    PARVASPSVPKsPTPKSPPSRparvin, alphaS5412.72
    PPP1CAyGQFSGLNPGGRPITPPRprotein phosphatase 1, catalytic subunit, alpha isozymeY3173.53
    PPP1CBYQYGGLNSGRPVtPPRprotein phosphatase 1, catalytic subunit, beta isozymeT3162.49
    PPP1R12ALAsTSDIEEKprotein phosphatase 1, regulatory subunit 12AS5075.55
    FPTTATKIsPKS4226.37
    VASPVQIYHNPtANSFRvasodilator-stimulated phosphoproteinT432.13
    VAV2ASsRsPVFTPRvav 2 guanine nucleotide exchange factorS769, S7710.50
    VCLILLRNPGNQAAyEHFETMKvinculinY6933.48
    DPSAsPGDAGEQAIRS29128.40
    ZYXFsPGAPGGSGSQPNQKzyxinS3414.23
    sPGAPGPLTLKS4047.30

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    • Supplemental Table S1 - A list of phosphoPSM identified by Sequest HT
    • Supplemental Table S2 - A list of identified phosphopeptides quantified by SILAC
    • Supplemental Table S3 - A list of identified phosphoproteins quantified by SILAC
    • Supplemental Figure S1 - Western blot analysis of key regulators and markers of EMT in MCF7-CTRL and MCF7-TamR cells. MDA-MB-231 and U2OS cells serve as positive control and &#x26;#61538;-actin serves as loading control.
PreviousNext
Back to top
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Molecular & Cellular Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer
(Your Name) has sent you a message from Molecular & Cellular Proteomics
(Your Name) thought you would like to see the Molecular & Cellular Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer
Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Raja Sekhar Nirujogi, Min-Sik Kim, Srikanth S. Manda, Vered Stearns, Edward Gabrielson, Saraswati Sukumar, Akhilesh Pandey
Molecular & Cellular Proteomics November 1, 2015, First published on September 1, 2015, 14 (11) 2887-2900; DOI: 10.1074/mcp.M115.050484

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Request Permissions

Share
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer
Xinyan Wu, Muhammad Saddiq Zahari, Santosh Renuse, Raja Sekhar Nirujogi, Min-Sik Kim, Srikanth S. Manda, Vered Stearns, Edward Gabrielson, Saraswati Sukumar, Akhilesh Pandey
Molecular & Cellular Proteomics November 1, 2015, First published on September 1, 2015, 14 (11) 2887-2900; DOI: 10.1074/mcp.M115.050484
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

In this issue

Molecular & Cellular Proteomics: 14 (11)
Molecular & Cellular Proteomics
Vol. 14, Issue 11
1 Nov 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • About the Cover
  • Index by author
  • Ed Board (PDF)

View this article with LENS

Jump to section

  • Article
    • Abstract
    • EXPERIMENTAL PROCEDURES
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

  • Follow MCP on Twitter
  • RSS feeds
  • Email

Articles

  • Current Issue
  • Papers in Press
  • Archive

For Authors

  • Submit a Manuscript
  • Info for Authors

Guidelines

  • Proteomic Identification
  • Clinical Proteomics
  • Glycomic Identification
  • Targeted Proteomics
  • Frequently Asked Questions

About MCP

  • About the Journal
  • Permissions and Licensing
  • Advertisers
  • Subscribers

ASBMB Publications

  • Molecular & Cellular Proteomics
  • Journal of Biological Chemistry
  • Journal of Lipid Research
  • ASBMB Today

© 2019 American Society for Biochemistry and Molecular Biology | Privacy Policy

MCP Print ISSN 1535-9476 Online ISSN 1535-9484

Powered by HighWire